Drug Type Small molecule drug |
Synonyms Glutathione/cisplatin, Glutoxim, BAM-002 + [1] |
Target- |
Mechanism DNA alkylating agents |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date RU (03 Jul 2001), |
Regulation- |
Molecular FormulaC10H17N3O6S |
InChIKeyRWSXRVCMGQZWBV-WDSKDSINSA-N |
CAS Registry70-18-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Neoplasms | RU | 03 Jul 2001 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Phase 3 | US | 01 Nov 2006 | |
Non-Small Cell Lung Cancer | Phase 3 | CA | 01 Nov 2006 | |
Non-Small Cell Lung Cancer | Phase 3 | IL | 01 Nov 2006 | |
Non-Small Cell Lung Cancer | Phase 3 | IT | 01 Nov 2006 | |
Non-Small Cell Lung Cancer | Phase 3 | PL | 01 Nov 2006 | |
Non-Small Cell Lung Cancer | Phase 3 | RO | 01 Nov 2006 | |
Non-Small Cell Lung Cancer | Phase 3 | RU | 01 Nov 2006 | |
Non-Small Cell Lung Cancer | Phase 3 | RS | 01 Nov 2006 | |
Non-Small Cell Lung Cancer | Phase 3 | ES | 01 Nov 2006 | |
Non-Small Cell Lung Cancer | Phase 3 | CH | 01 Nov 2006 |
Phase 2 | 15 | qrqwlakzsp(ebnslchvjy) = oqakngwvwf fliwpiriln (xkowashswx, amnpphwjmi - tybhzreiaf) View more | - | 10 Mar 2015 | |||
Phase 2 | HER2-negative breast cancer Neoadjuvant | 41 | ilqlcfoikw(fgpgdowvgh) = hyeygmvbjg dcswddpebt (ctrtojrftg ) | - | 01 Feb 2012 | ||
Phase 3 | 903 | urviwdjwoc(fkzbnfxacf) = bjiswevzew tseuzkgsva (zavsguyekg ) View more | Negative | 20 Jun 2010 | |||
urviwdjwoc(fkzbnfxacf) = pumksvmjym tseuzkgsva (zavsguyekg ) View more | |||||||
Phase 1/2 | Non-Small Cell Lung Cancer First line | 44 | dfwpwkrcfk(fnjcemejfv) = nzygfjzrod uksittbdtf (gmmbdrtejy ) View more | Positive | 20 Jun 2006 | ||
dfwpwkrcfk(fnjcemejfv) = plqkzpfrci uksittbdtf (gmmbdrtejy ) View more |